Anti-Bumping Granules Comprehensive Study by Type (Four Mesh Granules, Ten Mesh Granules, Twelve Mesh Granules), Application (Laboratory chemicals, Manufacture of substances,, Scientific R&D), Type (Solid, White), Sale channel (Online, Offline, Retailer, Distributor, Hypermarket/supermarket, Others) Players and Region - Global Market Outlook to 2028

Anti-Bumping Granules Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Anti-Bumping Granules Market Scope
An Anti-bumping granule is a tiny, unevenly shaped piece of substance or component which is added to liquids in order to make them boil more calmly and effectively. Anti-bumping granules are mostly used for the distillation and heating process. Anti-bumping granule is made from aluminum oxide, AI203. Geographically, the north leading region in the consumption and adoption of anti-bumping granules due to huge application in the manufacturing industry. Hence this is a factor that is triggering the market growth over the forecast period

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledTroemner LLC (United States), Merck (United States), Breckland Scientific (United Kingdom), VWR International, LLC (United Kingdom), BASF (Germany), Arkema (France), Nippon Shokubai (Japan), Mitsubishi Chemical (Japan), LG Chemical (South Korea), Evonik Industries (Germany), Dow Chemical Company (United States), Hexion(United States), OJSC Sibur (Moscow), Sasol (South Africa), Momentive Specialty Chemicals (United States) and Thomas Scientific (United States)
CAGR%


The market is expected to grow market in Manufacturing. It has been widely applied in well-sealing operations and is able to reduce pump pressure flow rate is driving the demand for the market. Several companies are operating in the market to provide customers with better offers with various features & unique offerings. The market is a highly consolidated market with the presence of several market players and local players. Which is triggering the market growth over the forecast period

Troemner LLC (United States), Merck (United States), Breckland Scientific (United Kingdom), VWR International, LLC (United Kingdom), BASF (Germany), Arkema (France), Nippon Shokubai (Japan), Mitsubishi Chemical (Japan), LG Chemical (South Korea), Evonik Industries (Germany), Dow Chemical Company (United States), Hexion(United States), OJSC Sibur (Moscow), Sasol (South Africa), Momentive Specialty Chemicals (United States) and Thomas Scientific (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Anti-Bumping Granules market by Type , by Application (Laboratory chemicals, Manufacture of substances, and Scientific R&D) and Region with country level break-up.

On the basis of geography, the market of Anti-Bumping Granules has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
On 21 January 2021, Thomas Scientific Accelerates Investments in Molecular Diagnostics Capabilities
On 19 August 2021, Thomas Scientific Launches Vendor Managed Inventory Solution


Market Growth Drivers:
Anti-bumping granule will prevent superheating of the liquid which being distilled and Anti-bumping granule will cause a more controlled boiler

Challenges:
Overheating may damage the quality of the product

Restraints:
During refluxing process is bumping (superheating) a large amount of stringing process is required

Opportunities:
It helps to cold the liquid and Anti-bumping granule mostly used for reflux procedure

Key Target Audience
Regulatory Authorities, New Entrants/Investors, Strategic Business Planners, Governments and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • Four Mesh Granules
  • Ten Mesh Granules
  • Twelve Mesh Granules
By Application
  • Laboratory chemicals
  • Manufacture of substances,
  • Scientific R&D
By Type
  • Solid
  • White

By Sale channel
  • Online
  • Offline
  • Retailer
  • Distributor
  • Hypermarket/supermarket
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Anti-bumping granule will prevent superheating of the liquid which being distilled
      • 3.2.2. Anti-bumping granule will cause a more controlled boiler
    • 3.3. Market Challenges
      • 3.3.1. Overheating may damage the quality of the product
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Anti-Bumping Granules, by Type, Application, Type, Sale channel and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Anti-Bumping Granules (Value)
      • 5.2.1. Global Anti-Bumping Granules by: Type (Value)
        • 5.2.1.1. Four Mesh Granules
        • 5.2.1.2. Ten Mesh Granules
        • 5.2.1.3. Twelve Mesh Granules
      • 5.2.2. Global Anti-Bumping Granules by: Type (Value)
        • 5.2.2.1. Solid
        • 5.2.2.2. White
      • 5.2.3. Global Anti-Bumping Granules by: Application (Value)
        • 5.2.3.1. Laboratory chemicals
        • 5.2.3.2. Manufacture of substances,
        • 5.2.3.3. Scientific R&D
      • 5.2.4. Global Anti-Bumping Granules by: Type (Value)
        • 5.2.4.1. Four Mesh Granules
        • 5.2.4.2. Ten Mesh Granules
        • 5.2.4.3. Twelve Mesh Granules
      • 5.2.5. Global Anti-Bumping Granules by: Type (Value)
        • 5.2.5.1. Solid
        • 5.2.5.2. White
      • 5.2.6. Global Anti-Bumping Granules by: Sale channel (Value)
        • 5.2.6.1. Online
        • 5.2.6.2. Offline
        • 5.2.6.3. Retailer
        • 5.2.6.4. Distributor
        • 5.2.6.5. Hypermarket/supermarket
        • 5.2.6.6. Others
      • 5.2.7. Global Anti-Bumping Granules Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
    • 5.3. Global Anti-Bumping Granules (Price)
      • 5.3.1. Global Anti-Bumping Granules by: Type (Price)
  • 6. Anti-Bumping Granules: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Troemner LLC (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Breckland Scientific (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. VWR International, LLC (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BASF (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Arkema (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nippon Shokubai (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mitsubishi Chemical (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. LG Chemical (South Korea)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Evonik Industries (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Dow Chemical Company (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Hexion(United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. OJSC Sibur (Moscow)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Sasol (South Africa)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Momentive Specialty Chemicals (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Thomas Scientific (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Anti-Bumping Granules Sale, by Type, Application, Type, Sale channel and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Anti-Bumping Granules (Value)
      • 7.2.1. Global Anti-Bumping Granules by: Type (Value)
        • 7.2.1.1. Four Mesh Granules
        • 7.2.1.2. Ten Mesh Granules
        • 7.2.1.3. Twelve Mesh Granules
      • 7.2.2. Global Anti-Bumping Granules by: Type (Value)
        • 7.2.2.1. Solid
        • 7.2.2.2. White
      • 7.2.3. Global Anti-Bumping Granules by: Application (Value)
        • 7.2.3.1. Laboratory chemicals
        • 7.2.3.2. Manufacture of substances,
        • 7.2.3.3. Scientific R&D
      • 7.2.4. Global Anti-Bumping Granules by: Type (Value)
        • 7.2.4.1. Four Mesh Granules
        • 7.2.4.2. Ten Mesh Granules
        • 7.2.4.3. Twelve Mesh Granules
      • 7.2.5. Global Anti-Bumping Granules by: Type (Value)
        • 7.2.5.1. Solid
        • 7.2.5.2. White
      • 7.2.6. Global Anti-Bumping Granules by: Sale channel (Value)
        • 7.2.6.1. Online
        • 7.2.6.2. Offline
        • 7.2.6.3. Retailer
        • 7.2.6.4. Distributor
        • 7.2.6.5. Hypermarket/supermarket
        • 7.2.6.6. Others
      • 7.2.7. Global Anti-Bumping Granules Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
    • 7.3. Global Anti-Bumping Granules (Price)
      • 7.3.1. Global Anti-Bumping Granules by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Anti-Bumping Granules: by Type(USD Million)
  • Table 2. Anti-Bumping Granules Four Mesh Granules , by Region USD Million (2017-2022)
  • Table 3. Anti-Bumping Granules Ten Mesh Granules , by Region USD Million (2017-2022)
  • Table 4. Anti-Bumping Granules Twelve Mesh Granules , by Region USD Million (2017-2022)
  • Table 5. Anti-Bumping Granules: by Type(USD Million)
  • Table 6. Anti-Bumping Granules Solid , by Region USD Million (2017-2022)
  • Table 7. Anti-Bumping Granules White , by Region USD Million (2017-2022)
  • Table 8. Anti-Bumping Granules: by Application(USD Million)
  • Table 9. Anti-Bumping Granules Laboratory chemicals , by Region USD Million (2017-2022)
  • Table 10. Anti-Bumping Granules Manufacture of substances, , by Region USD Million (2017-2022)
  • Table 11. Anti-Bumping Granules Scientific R&D , by Region USD Million (2017-2022)
  • Table 12. Anti-Bumping Granules: by Type(USD Million)
  • Table 13. Anti-Bumping Granules Four Mesh Granules , by Region USD Million (2017-2022)
  • Table 14. Anti-Bumping Granules Ten Mesh Granules , by Region USD Million (2017-2022)
  • Table 15. Anti-Bumping Granules Twelve Mesh Granules , by Region USD Million (2017-2022)
  • Table 16. Anti-Bumping Granules: by Type(USD Million)
  • Table 17. Anti-Bumping Granules Solid , by Region USD Million (2017-2022)
  • Table 18. Anti-Bumping Granules White , by Region USD Million (2017-2022)
  • Table 19. Anti-Bumping Granules: by Sale channel(USD Million)
  • Table 20. Anti-Bumping Granules Online , by Region USD Million (2017-2022)
  • Table 21. Anti-Bumping Granules Offline , by Region USD Million (2017-2022)
  • Table 22. Anti-Bumping Granules Retailer , by Region USD Million (2017-2022)
  • Table 23. Anti-Bumping Granules Distributor , by Region USD Million (2017-2022)
  • Table 24. Anti-Bumping Granules Hypermarket/supermarket , by Region USD Million (2017-2022)
  • Table 25. Anti-Bumping Granules Others , by Region USD Million (2017-2022)
  • Table 26. South America Anti-Bumping Granules, by Country USD Million (2017-2022)
  • Table 27. South America Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 28. South America Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 29. South America Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 30. South America Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 31. Brazil Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 32. Brazil Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 33. Brazil Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 34. Brazil Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 35. Argentina Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 36. Argentina Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 37. Argentina Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 38. Argentina Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 39. Rest of South America Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 40. Rest of South America Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 41. Rest of South America Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 42. Rest of South America Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 43. Asia Pacific Anti-Bumping Granules, by Country USD Million (2017-2022)
  • Table 44. Asia Pacific Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 45. Asia Pacific Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 46. Asia Pacific Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 47. Asia Pacific Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 48. China Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 49. China Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 50. China Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 51. China Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 52. Japan Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 53. Japan Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 54. Japan Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 55. Japan Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 56. India Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 57. India Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 58. India Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 59. India Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 60. South Korea Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 61. South Korea Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 62. South Korea Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 63. South Korea Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 64. Taiwan Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 65. Taiwan Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 66. Taiwan Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 67. Taiwan Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 68. Australia Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 69. Australia Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 70. Australia Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 71. Australia Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 72. Rest of Asia-Pacific Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 73. Rest of Asia-Pacific Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 74. Rest of Asia-Pacific Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 75. Rest of Asia-Pacific Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 76. Europe Anti-Bumping Granules, by Country USD Million (2017-2022)
  • Table 77. Europe Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 78. Europe Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 79. Europe Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 80. Europe Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 81. Germany Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 82. Germany Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 83. Germany Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 84. Germany Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 85. France Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 86. France Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 87. France Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 88. France Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 89. Italy Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 90. Italy Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 91. Italy Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 92. Italy Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 93. United Kingdom Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 94. United Kingdom Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 95. United Kingdom Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 96. United Kingdom Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 97. Netherlands Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 98. Netherlands Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 99. Netherlands Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 100. Netherlands Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 101. Rest of Europe Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 102. Rest of Europe Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 103. Rest of Europe Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 104. Rest of Europe Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 105. MEA Anti-Bumping Granules, by Country USD Million (2017-2022)
  • Table 106. MEA Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 107. MEA Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 108. MEA Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 109. MEA Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 110. Middle East Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 111. Middle East Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 112. Middle East Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 113. Middle East Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 114. Africa Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 115. Africa Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 116. Africa Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 117. Africa Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 118. North America Anti-Bumping Granules, by Country USD Million (2017-2022)
  • Table 119. North America Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 120. North America Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 121. North America Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 122. North America Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 123. United States Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 124. United States Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 125. United States Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 126. United States Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 127. Canada Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 128. Canada Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 129. Canada Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 130. Canada Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 131. Mexico Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 132. Mexico Anti-Bumping Granules, by Application USD Million (2017-2022)
  • Table 133. Mexico Anti-Bumping Granules, by Type USD Million (2017-2022)
  • Table 134. Mexico Anti-Bumping Granules, by Sale channel USD Million (2017-2022)
  • Table 135. Anti-Bumping Granules: by Type(USD/Units)
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. Company Basic Information, Sales Area and Its Competitors
  • Table 151. Company Basic Information, Sales Area and Its Competitors
  • Table 152. Anti-Bumping Granules: by Type(USD Million)
  • Table 153. Anti-Bumping Granules Four Mesh Granules , by Region USD Million (2023-2028)
  • Table 154. Anti-Bumping Granules Ten Mesh Granules , by Region USD Million (2023-2028)
  • Table 155. Anti-Bumping Granules Twelve Mesh Granules , by Region USD Million (2023-2028)
  • Table 156. Anti-Bumping Granules: by Type(USD Million)
  • Table 157. Anti-Bumping Granules Solid , by Region USD Million (2023-2028)
  • Table 158. Anti-Bumping Granules White , by Region USD Million (2023-2028)
  • Table 159. Anti-Bumping Granules: by Application(USD Million)
  • Table 160. Anti-Bumping Granules Laboratory chemicals , by Region USD Million (2023-2028)
  • Table 161. Anti-Bumping Granules Manufacture of substances, , by Region USD Million (2023-2028)
  • Table 162. Anti-Bumping Granules Scientific R&D , by Region USD Million (2023-2028)
  • Table 163. Anti-Bumping Granules: by Type(USD Million)
  • Table 164. Anti-Bumping Granules Four Mesh Granules , by Region USD Million (2023-2028)
  • Table 165. Anti-Bumping Granules Ten Mesh Granules , by Region USD Million (2023-2028)
  • Table 166. Anti-Bumping Granules Twelve Mesh Granules , by Region USD Million (2023-2028)
  • Table 167. Anti-Bumping Granules: by Type(USD Million)
  • Table 168. Anti-Bumping Granules Solid , by Region USD Million (2023-2028)
  • Table 169. Anti-Bumping Granules White , by Region USD Million (2023-2028)
  • Table 170. Anti-Bumping Granules: by Sale channel(USD Million)
  • Table 171. Anti-Bumping Granules Online , by Region USD Million (2023-2028)
  • Table 172. Anti-Bumping Granules Offline , by Region USD Million (2023-2028)
  • Table 173. Anti-Bumping Granules Retailer , by Region USD Million (2023-2028)
  • Table 174. Anti-Bumping Granules Distributor , by Region USD Million (2023-2028)
  • Table 175. Anti-Bumping Granules Hypermarket/supermarket , by Region USD Million (2023-2028)
  • Table 176. Anti-Bumping Granules Others , by Region USD Million (2023-2028)
  • Table 177. South America Anti-Bumping Granules, by Country USD Million (2023-2028)
  • Table 178. South America Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 179. South America Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 180. South America Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 181. South America Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 182. Brazil Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 183. Brazil Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 184. Brazil Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 185. Brazil Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 186. Argentina Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 187. Argentina Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 188. Argentina Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 189. Argentina Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 190. Rest of South America Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 191. Rest of South America Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 192. Rest of South America Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 193. Rest of South America Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 194. Asia Pacific Anti-Bumping Granules, by Country USD Million (2023-2028)
  • Table 195. Asia Pacific Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 196. Asia Pacific Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 197. Asia Pacific Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 198. Asia Pacific Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 199. China Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 200. China Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 201. China Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 202. China Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 203. Japan Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 204. Japan Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 205. Japan Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 206. Japan Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 207. India Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 208. India Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 209. India Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 210. India Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 211. South Korea Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 212. South Korea Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 213. South Korea Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 214. South Korea Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 215. Taiwan Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 216. Taiwan Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 217. Taiwan Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 218. Taiwan Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 219. Australia Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 220. Australia Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 221. Australia Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 222. Australia Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 223. Rest of Asia-Pacific Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 224. Rest of Asia-Pacific Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 225. Rest of Asia-Pacific Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 226. Rest of Asia-Pacific Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 227. Europe Anti-Bumping Granules, by Country USD Million (2023-2028)
  • Table 228. Europe Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 229. Europe Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 230. Europe Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 231. Europe Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 232. Germany Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 233. Germany Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 234. Germany Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 235. Germany Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 236. France Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 237. France Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 238. France Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 239. France Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 240. Italy Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 241. Italy Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 242. Italy Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 243. Italy Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 244. United Kingdom Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 245. United Kingdom Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 246. United Kingdom Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 247. United Kingdom Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 248. Netherlands Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 249. Netherlands Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 250. Netherlands Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 251. Netherlands Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 252. Rest of Europe Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 253. Rest of Europe Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 254. Rest of Europe Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 255. Rest of Europe Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 256. MEA Anti-Bumping Granules, by Country USD Million (2023-2028)
  • Table 257. MEA Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 258. MEA Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 259. MEA Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 260. MEA Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 261. Middle East Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 262. Middle East Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 263. Middle East Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 264. Middle East Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 265. Africa Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 266. Africa Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 267. Africa Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 268. Africa Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 269. North America Anti-Bumping Granules, by Country USD Million (2023-2028)
  • Table 270. North America Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 271. North America Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 272. North America Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 273. North America Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 274. United States Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 275. United States Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 276. United States Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 277. United States Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 278. Canada Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 279. Canada Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 280. Canada Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 281. Canada Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 282. Mexico Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 283. Mexico Anti-Bumping Granules, by Application USD Million (2023-2028)
  • Table 284. Mexico Anti-Bumping Granules, by Type USD Million (2023-2028)
  • Table 285. Mexico Anti-Bumping Granules, by Sale channel USD Million (2023-2028)
  • Table 286. Anti-Bumping Granules: by Type(USD/Units)
  • Table 287. Research Programs/Design for This Report
  • Table 288. Key Data Information from Secondary Sources
  • Table 289. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Anti-Bumping Granules: by Type USD Million (2017-2022)
  • Figure 5. Global Anti-Bumping Granules: by Type USD Million (2017-2022)
  • Figure 6. Global Anti-Bumping Granules: by Application USD Million (2017-2022)
  • Figure 7. Global Anti-Bumping Granules: by Type USD Million (2017-2022)
  • Figure 8. Global Anti-Bumping Granules: by Type USD Million (2017-2022)
  • Figure 9. Global Anti-Bumping Granules: by Sale channel USD Million (2017-2022)
  • Figure 10. South America Anti-Bumping Granules Share (%), by Country
  • Figure 11. Asia Pacific Anti-Bumping Granules Share (%), by Country
  • Figure 12. Europe Anti-Bumping Granules Share (%), by Country
  • Figure 13. MEA Anti-Bumping Granules Share (%), by Country
  • Figure 14. North America Anti-Bumping Granules Share (%), by Country
  • Figure 15. Global Anti-Bumping Granules: by Type USD/Units (2017-2022)
  • Figure 16. Global Anti-Bumping Granules share by Players 2022 (%)
  • Figure 17. Global Anti-Bumping Granules share by Players (Top 3) 2022(%)
  • Figure 18. Global Anti-Bumping Granules share by Players (Top 5) 2022(%)
  • Figure 19. BCG Matrix for key Companies
  • Figure 20. Troemner LLC (United States) Revenue, Net Income and Gross profit
  • Figure 21. Troemner LLC (United States) Revenue: by Geography 2022
  • Figure 22. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 23. Merck (United States) Revenue: by Geography 2022
  • Figure 24. Breckland Scientific (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Breckland Scientific (United Kingdom) Revenue: by Geography 2022
  • Figure 26. VWR International, LLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. VWR International, LLC (United Kingdom) Revenue: by Geography 2022
  • Figure 28. BASF (Germany) Revenue, Net Income and Gross profit
  • Figure 29. BASF (Germany) Revenue: by Geography 2022
  • Figure 30. Arkema (France) Revenue, Net Income and Gross profit
  • Figure 31. Arkema (France) Revenue: by Geography 2022
  • Figure 32. Nippon Shokubai (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Nippon Shokubai (Japan) Revenue: by Geography 2022
  • Figure 34. Mitsubishi Chemical (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Mitsubishi Chemical (Japan) Revenue: by Geography 2022
  • Figure 36. LG Chemical (South Korea) Revenue, Net Income and Gross profit
  • Figure 37. LG Chemical (South Korea) Revenue: by Geography 2022
  • Figure 38. Evonik Industries (Germany) Revenue, Net Income and Gross profit
  • Figure 39. Evonik Industries (Germany) Revenue: by Geography 2022
  • Figure 40. Dow Chemical Company (United States) Revenue, Net Income and Gross profit
  • Figure 41. Dow Chemical Company (United States) Revenue: by Geography 2022
  • Figure 42. Hexion(United States) Revenue, Net Income and Gross profit
  • Figure 43. Hexion(United States) Revenue: by Geography 2022
  • Figure 44. OJSC Sibur (Moscow) Revenue, Net Income and Gross profit
  • Figure 45. OJSC Sibur (Moscow) Revenue: by Geography 2022
  • Figure 46. Sasol (South Africa) Revenue, Net Income and Gross profit
  • Figure 47. Sasol (South Africa) Revenue: by Geography 2022
  • Figure 48. Momentive Specialty Chemicals (United States) Revenue, Net Income and Gross profit
  • Figure 49. Momentive Specialty Chemicals (United States) Revenue: by Geography 2022
  • Figure 50. Thomas Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 51. Thomas Scientific (United States) Revenue: by Geography 2022
  • Figure 52. Global Anti-Bumping Granules: by Type USD Million (2023-2028)
  • Figure 53. Global Anti-Bumping Granules: by Type USD Million (2023-2028)
  • Figure 54. Global Anti-Bumping Granules: by Application USD Million (2023-2028)
  • Figure 55. Global Anti-Bumping Granules: by Type USD Million (2023-2028)
  • Figure 56. Global Anti-Bumping Granules: by Type USD Million (2023-2028)
  • Figure 57. Global Anti-Bumping Granules: by Sale channel USD Million (2023-2028)
  • Figure 58. South America Anti-Bumping Granules Share (%), by Country
  • Figure 59. Asia Pacific Anti-Bumping Granules Share (%), by Country
  • Figure 60. Europe Anti-Bumping Granules Share (%), by Country
  • Figure 61. MEA Anti-Bumping Granules Share (%), by Country
  • Figure 62. North America Anti-Bumping Granules Share (%), by Country
  • Figure 63. Global Anti-Bumping Granules: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Troemner LLC (United States)
  • Merck (United States)
  • Breckland Scientific (United Kingdom)
  • VWR International, LLC (United Kingdom)
  • BASF (Germany)
  • Arkema (France)
  • Nippon Shokubai (Japan)
  • Mitsubishi Chemical (Japan)
  • LG Chemical (South Korea)
  • Evonik Industries (Germany)
  • Dow Chemical Company (United States)
  • Hexion(United States)
  • OJSC Sibur (Moscow)
  • Sasol (South Africa)
  • Momentive Specialty Chemicals (United States)
  • Thomas Scientific (United States)
Select User Access Type

Key Highlights of Report


Apr 2023 232 Pages 63 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Anti-Bumping Granules Market are by type [Four Mesh Granules, Ten Mesh Granules and Twelve Mesh Granules], by end use application [Laboratory chemicals, Manufacture of substances, and Scientific R&D].
The Anti-Bumping Granules Market is gaining popularity and expected to see strong valuation by 2028.
  • Anti-bumping granule will prevent superheating of the liquid which being distilled
  • Anti-bumping granule will cause a more controlled boiler

Know More About Global Anti-Bumping Granules Report?